The Use of Radiomic Features to Predict Human Papillomavirus (HPV) Status in Head and Neck Tumors: A Review.
| Autor: | Glogauer J; Department of Pathology and Molecular Medicine, McMaster University, Waterloo, CAN., Kohanzadeh A; Medical School, Albert Einstein College of Medicine, Bronx, USA., Feit A; Medical School, Albert Einstein College of Medicine, Bronx, USA., Fournier JE; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, CAN., Zians A; Department of Diagnostic and Interventional Radiology, Montefiore Medical Center, Wakefield Campus, Bronx, USA., Somogyi DZ; Department of Internal Medicine, Westchester Medical Center, Valhalla, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Aug 31; Vol. 15 (8), pp. e44476. Date of Electronic Publication: 2023 Aug 31 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.44476 |
| Abstrakt: | Head and neck cancers represent a significant source of morbidity and mortality across the world. The individual genetic makeup of each tumor can help to determine the course of treatment and can help clinicians predict prognosis. Non-invasive tools to determine the genetic status of these tumors, particularly p16 (human papillomavirus (HPV)) status could prove extremely valuable to treating clinicians and surgeons. The field of radiomics is a burgeoning area of radiology practice that aims to provide quantitative biomarkers that can be derived from radiological images and could prove useful in determining p16 status non-invasively. In this review, we summarize the current evidence for the use of radiomics to determine the HPV status of head and neck tumors. . Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Glogauer et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|